Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetics of Mitotane in Adrenocortical Carcinoma
NL-OMON42303Active, not recruiting
- Sponsor
- Máxima Medisch Centrum
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mitotane in adrenal cancer (ACC), sponsored by Máxima Medisch Centrum. Primary endpoint: Association between ADME SNPs and mitotane clearance. Started Mar 2015; status: active, not recruiting.
02
Drugs
mitotane
03
Conditions
adrenal cancer (ACC)
Beyond the preview
Go deeper on NL-OMON42303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42303.